| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:10:05 -0700 |
| HMDB ID |
HMDB01198 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Leukotriene C4 |
| Description |
Leukotriene C4 (LTC4) is a cysteinyl leukotriene (CysLT), a family of potent inflammatory mediators. Eosinophils, one of the principal cell types recruited to and activated at sites of allergic inflammation, is capable of elaborating lipid mediators, including leukotrienes derived from the oxidative metabolism of arachidonic acid (AA). Potentially 'activated' eosinophils may elaborate greater quantities of LTC4, than normal eosinophils. These activated eosinophils thus are 'primed' for enhanced LTC4 generation in response to subsequent stimuli. Some recognized priming stimuli are chemoattractants (e.g., eotaxin, PAF) that may participate in the recruitment of eosinophils to sites of allergic inflammation. The mechanisms by which chemoattractants and other activating cytokines (e.g., interleukin (IL)-5) or extracellular matrix components (e.g., fibronectin) enhance eosinophil eicosanoid formation are pertinent to the functions of these eicosanoids as paracrine mediators of allergic inflammation. Some eosinophil-derived eicosanoids may be active in down-regulating inflammation. It is increasingly likely that eicosanoids synthesized within cells, including eosinophils, may have intracellular (e.g., intracrine) roles in regulating cell functions, in addition to the more recognized activities of eicosanoids as paracrine mediators of inflammation. Acting extracellularly, the cysteinyl leukotrienes (CysLTs) LTC4 and its extracellular derivatives, LTD4 and LTE4 are key paracrine mediators pertinent to asthma and allergic diseases. Based on their receptor-mediated capabilities, they can elicit bronchoconstriction, mucous hypersecretion, bronchial hyperresponsiveness, increased microvascular permeability, and additional eosinophil infiltration. Eosinophils are a major source of CysLTs and have been identified as the principal LTC4 synthase expressing cells in bronchial mucosal biopsies of asthmatic subjects. (PMID: 12895596 )Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-gamma-glutamyl-L-cysteinyl)-Glycine
- 5S,6R-Ltc
- 5S-Hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoate
- 5S-Hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic acid
- L-gamma-Glutamyl-S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]-2,4,6,9-pentadecatetraenyl]-L-cysteinyl-glycine
- Leucotriene C4
- Leukotriene C
- Leukotriene C1
- Leukotriene C4
- LTC
- LTC4
- [R-[R*,S*-(E,E,Z,Z)]]-N-[S-[1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl]-N-L-gamma-glutamyl-L-cysteinyl]-Glycine 5S,6R-LTC4
|
| Chemical Formula |
C30H47N3O9S |
| Average Molecular Weight |
625.774 |
| Monoisotopic Molecular Weight |
625.303300807 |
| IUPAC Name |
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-[(4S)-4-amino-4-carboxybutanamido]-2-[(carboxymethyl)carbamoyl]ethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid |
| Traditional IUPAC Name |
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-[(4S)-4-amino-4-carboxybutanamido]-2-(carboxymethylcarbamoyl)ethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid |
| CAS Registry Number |
72025-60-6 |
| SMILES |
CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O |
| InChI Identifier |
InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1 |
| InChI Key |
GWNVDXQDILPJIG-NXOLIXFESA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Peptides |
| Sub Class |
N/A |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Hydroxy Fatty Acids
- Leukotrienes
- Organic Compounds
- Thia Fatty Acids
- Unsaturated Fatty Acids
|
| Substituents |
- Acyclic Alkene
- Alpha Amino Acid Or Derivative
- Carboxamide Group
- Carboxylic Acid
- Hydroxyeicosatetraenoic Acid
- N Acyl Alpha Amino Acid
- N Acylglycine
- N Substituted Alpha Amino Acid
- Primary Aliphatic Amine (Alkylamine)
- Secondary Alcohol
- Secondary Carboxylic Acid Amide
- Thioether
- Tricarboxylic Acid Derivative
|
| Direct Parent |
Peptides |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Prostaglandin and leukotriene metabolism
|
| Application |
Not Available |
| Cellular locations |
- Extracellular
- Endoplasmic reticulum
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Endoplasmic reticulum
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
|
| Tissue Location |
- Intestine
- Skin
- Platelet
- Lens
- Neutrophil
- Leukocyte
- Smooth Muscle
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
4.7E-5 +/- 2.3E-5 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.001359 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.00006 +/- 0.00003 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.989e-05 +/- 2.767e-05 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000133 +/- 3.454e-05 uM |
Children (1-13 year old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000101 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
7.996e-05 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
1.791e-05 +/- 4.798e-06 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.00024 +/- 0.000065 uM |
Adult (>18 years old) |
Both |
Eczema |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000153 +/- 1.711e-05 uM |
Adult (>18 years old) |
Not Specified |
Spinal cord injuries (acute stage) |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000557 uM |
Not Specified |
Not Specified |
AIDS |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000185 +/- 7.628e-05 uM |
Children (1-13 year old) |
Not Specified |
Aseptic meningitis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
<7.996e-05 uM |
Not Specified |
Not Specified |
closed head |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
1.343e-05 uM |
Adult (>18 years old) |
Male |
glutathione synthetase deficiency, acute metabolic crisis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
<7.996e-05 uM |
Not Specified |
Not Specified |
gunshot wound |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000422 uM |
Not Specified |
Not Specified |
HIV positive |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2.399e-05 uM |
Not Specified |
Not Specified |
HIV-Seropositive, Dementia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
<0.000160 uM |
Not Specified |
Not Specified |
hydrocephalus |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00413 +/- 0.000611 uM |
Not Specified |
Not Specified |
subarachnoid hemorrhage with cerebral vasospasm |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000280 uM |
Not Specified |
Not Specified |
HIV-Seropositive (Neurologically normal) |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00130 +/- 0.000227 uM |
Not Specified |
Not Specified |
subarachnoid hemorrhage without cerebral vasospasm |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Eczema |
- Hua Z, Fei H, Mingming X: Evaluation and interference of serum and skin lesion levels of leukotrienes in patients with eczema. Prostaglandins Leukot Essent Fatty Acids. 2006 Jul;75(1):51-5. Epub 2006 Jun 6.
Pubmed: 16757158
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022484 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4444133  |
| KEGG Compound ID |
C02166  |
| BioCyc ID |
LEUKOTRIENE-C4  |
| BiGG ID |
2212273  |
| Wikipedia Link |
Leukotriene C4  |
| NuGOwiki Link |
HMDB01198  |
| Metagene Link |
HMDB01198  |
| METLIN ID |
3681  |
| PubChem Compound |
5280493  |
| PDB ID |
Not Available |
| ChEBI ID |
16978  |
| References |
| Synthesis Reference |
Rokach, Joshua; Young, Robert N.; Kakushima, Masatoshi; Lau, Cheuk-Kun; Seguin, Rick; Frenette, Richard; Guindon, Yvan. Synthesis of leukotrienes. New synthesis of natural leukotriene A4. Tetrahedron Letters (1981), 22(11), 979-82. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Sawazaki Y: [Leukotriene B4, leukotriene C4 and prostaglandin E2 in the serum, synovial fluid and synovium in patients with rheumatoid arthritis] Nippon Ika Daigaku Zasshi. 1989 Dec;56(6):559-64.
Pubmed: 2558123
- Heimburger M, Palmblad JE: Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils. Clin Exp Immunol. 1996 Mar;103(3):454-60.
Pubmed: 8608646
- Lane SJ, Lee TH: Mast cell effector mechanisms. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S67-71; discussion S71-2.
Pubmed: 8939179
- Romero R, Wu YK, Mazor M, Hobbins JC, Mitchell MD: Increased amniotic fluid leukotriene C4 concentration in term human parturition. Am J Obstet Gynecol. 1988 Sep;159(3):655-7.
Pubmed: 3421265
- Paoletti P, Gaetani P, Grignani G, Pacchiarini L, Silvani V, Rodriguez y Baena R: CSF leukotriene C4 following subarachnoid hemorrhage. J Neurosurg. 1988 Oct;69(4):488-93.
Pubmed: 3418380
- De Servi S, Ricevuti G, Mazzone A, Pasotti D, Bramucci E, Angoli L, Specchia G: Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease. J Am Coll Cardiol. 1991 Apr;17(5):1125-8.
Pubmed: 2007712
- Koshino T, Takano S, Houjo T, Sano Y, Kudo K, Kihara H, Kitani S, Takaishi T, Hirai K, Ito K, Morita Y: Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics. Biochem Biophys Res Commun. 1998 Jun 18;247(2):510-3.
Pubmed: 9642160
- Richter L, Hesselbarth N, Eitner K, Schubert K, Bosseckert H, Krell H: Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction. J Hepatol. 1996 Nov;25(5):725-32.
Pubmed: 8938552
- Sternfeld M, Fink A, Bentwich Z, Eliraz A: The role of acupuncture in asthma: changes in airways dynamics and LTC4 induced LAI. Am J Chin Med. 1989;17(3-4):129-34.
Pubmed: 2633615
- Ponicke K, Forster W: Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets. Biomed Biochim Acta. 1984;43(8-9):S459-62.
Pubmed: 6440558
- Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD: Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol. 2005 Feb;67(2):545-57. Epub 2004 Nov 10.
Pubmed: 15537867
- Sjolinder M, Tornhamre S, Claesson HE, Hydman J, Lindgren J: Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J Lipid Res. 1999 Mar;40(3):439-46.
Pubmed: 10064732
- Angi MR, Bettero A, Filippi F, Salvalaio L, Benassi CA: [Quantitative evaluation of conjunctival irritation by simultaneous determination of histamine, serotonin and leukotriene C4 in tears] Ophtalmologie. 1987 Oct-Dec;1(4):509-11.
Pubmed: 3153930
- Cruz JR, Cano F, Razin E, Acheson DW, Keusch GT: Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae. J Pediatr Gastroenterol Nutr. 1995 Feb;20(2):179-83.
Pubmed: 7714683
- Zijlstra FJ, Wilson JH: 15-HETE is the main eicosanoid present in mucus of ulcerative proctocolitis. Prostaglandins Leukot Essent Fatty Acids. 1991 May;43(1):55-9.
Pubmed: 1652771
- Matsumoto S, Hayashi Y, Kinoshita I, Ikata T, Yamamoto S: Immunoaffinity purification of prostaglandin E2 and leukotriene C4 prior to radioimmunoassay: application to human synovial fluid. Ann Clin Biochem. 1993 Jan;30 ( Pt 1):60-8.
Pubmed: 8434868
- Talbot SF, Atkins PC, Goetzl EJ, Zweiman B: Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest. 1985 Aug;76(2):650-6.
Pubmed: 2411760
- Kloprogge E, de Leeuw AJ, de Monchy JG, Kauffman HF: Cellular communication in leukotriene C4 production between eosinophils and neutrophils. Int Arch Allergy Appl Immunol. 1989;90(1):20-3.
Pubmed: 2509375
- Damtew B, Spagnuolo PJ: Leukotriene C4 from vascular endothelium enhances neutrophil adhesiveness. Prostaglandins Leukot Essent Fatty Acids. 1997 Feb;56(2):111-6.
Pubmed: 9051719
- Schauer U, Eckhart A, Muller R, Gemsa D, Rieger CH: Enhanced leukotriene C4 production by peripheral eosinophilic granulocytes from children with asthma. Int Arch Allergy Appl Immunol. 1989;90(3):201-6.
Pubmed: 2512259
|